NOV
40
-2
D
48
3
ECL
59
5
FOX
60
-2
AA
53
2
YUM
58
2
COST
44
-3
CINF
41
4
AEP
61
2
RHI
27
2
EBAY
49
-10
EXR
37
6
INTC
49
-3
CCL
67
2
LLY
68
4
WYNN
45
-3
NEE
54
-11
PNC
59
2
PHM
46
3
FE
35
-2
NOV
40
-2
D
48
3
ECL
59
5
FOX
60
-2
AA
53
2
YUM
58
2
COST
44
-3
CINF
41
4
AEP
61
2
RHI
27
2
EBAY
49
-10
EXR
37
6
INTC
49
-3
CCL
67
2
LLY
68
4
WYNN
45
-3
NEE
54
-11
PNC
59
2
PHM
46
3
FE
35
-2
Financhill
Back

Repligen Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45

RGEN
Repligen

Last Price:
$124.01
Seasonality Move:
4.64%

7 Day Trial

ALL ACCESS PASS

$ 7

Repligen Stock Forecast

  • Over the next 52 weeks, Repligen has on average historically risen by 25.8% based on the past 39 years of stock performance.
  • Repligen has risen higher in 24 of those 39 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.54%
  • Is Repligen Stock Undervalued?
    The current Repligen [RGEN] share price is $119.75. The Score for RGEN is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Repligen Stock Go Up Next Year?

  • Over the next 52 weeks, Repligen has on average historically risen by 25.8% based on the past 39 years of stock performance.

Repligen Stock Rating

Sell
45
Repligen (RGEN) is a Sell

Is Repligen overpriced?

  • Repligen has risen higher in 24 of those 39 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.54%

Repligen Stock Price History

Is RGEN stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGEN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
repligen.com

52-Week Data

52-Week High:
182.52
52-Week Low:
102.97

Prediction Charts

Market Cap:
6.7B
Price in USD:
119.75
Volume:
690.1K
Beta:
0.98

Technical Analysis

SMA50:
125.58
SMA100:
133.04
SMA200:
140.56
52-Wk Change:
-11.3%

Stock Predictions

  • Is Repligen stock public?
    Yes, Repligen is a publicly traded company.
  • What is the Repligen stock quote today?
    The Repligen stock price is 119.75 USD today.
  • How to buy Repligen stock online?
    You can buy Repligen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-26 124.21 124.21 125.54 121.99
Jun-27 124.53 123.56 125.05 121.44
Jun-30 123.75 124.38 126.04 122.62
Jul-1 124.02 126.44 131.43 123.10
Jul-2 126.39 126.96 128.19 125.63
Jul-3 129.11 127.47 129.11 126.49
Jul-7 126.23 124.43 127.45 123.34
Jul-8 124.73 128.56 129.38 124.38
Jul-9 128.47 129.82 130.82 127.84
Jul-10 130.64 134.00 135.02 129.15
Jul-11 132.58 130.19 135.57 129.63
Jul-14 128.25 121.33 128.25 120.89
Jul-15 122.26 118.10 122.32 117.98
Jul-16 119.92 119.75 120.51 117.39

Repligen Earnings

Repligen Earnings Report: Per Share Repligen Earnings Q1 Q2 Q3 and Q4 last year and next year.

Repligen Forecast Revenue Growth

Repligen Stock Analysis: Historical quarterly revenues per share for Repligen and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.13 per share, an increase this year of $0.15 per share, and an increase next year of $0.48 per share.

* Repligen stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.